BRAF and neoplasm: While dabrafenib directly inhibits BRAF activity [32], HT induced a broader suppression of oncogenic proteins involved in tumor-stroma crosstalk and angiogenesis, including VEGFR-2, WIF-1, ITGB5, and ERBB2/3/4.